Compare Nuwellis Inc (NUWE) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Wix.Com Ltd — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Wix.Com Ltd trades at $74.3 (market cap $3.11B). The key difference: Wix.Com Ltd is far larger — about 1224.4× Nuwellis Inc's market cap, and Wix.Com Ltd is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | WIX | |
|---|---|---|
Market Cap | $2.54M | $3.11B |
Sector | Technology | Technology |
52-Week High | $164.50 | $184.24 |
52-Week Low | $0.73 | $40.43 |
Enterprise Value | -$1.17M | $4.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% on the day, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth but deep losses, with a net income margin of -125.63% in 2026. Recent developments include a reverse stock split, leadership changes, and strategic expansions in pediatric care, supported by positive gross margin improvements and new partnerships.
Outlook remains speculative; growth opportunities exist in market expansion and product development, but high cash burn, negative profitability, and reliance on financing pose significant risks. Analyst sentiment is mixed, with equal buy/hold ratings, reflecting uncertainty about the path to profitability.
WIX trades at $72.72, down 4.58% amid technical bearish signals and multiple securities class action lawsuits. The company shows revenue growth to $1.99B in 2025 but faces profitability challenges with a negative net income margin of -8.19%. Recent earnings were mixed with Q1 2026 missing expectations while Q2 2026 beat estimates. Cash flow trends show operational strength but significant investing outflows.
Analyst consensus remains positive with 63% buy ratings and $73.36 price target, but legal risks and competitive pressures create headwinds. The stock presents a high-risk opportunity with potential upside if legal issues resolve and AI product execution improves, though current technical weakness suggests caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
